Nika Pharmaceuticals, Inc.

OTCPK:NIKA Stock Report

Market Cap: US$317.9m

Nika Pharmaceuticals Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Dimitar Savov

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.4yrs
CEO ownership31.6%
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates


CEO

Dimitar Savov (66 yo)

2.4yrs

Tenure

Mr. Dimitar Slavchev Savov is President, CEO, CFO & Director of Nika Pharmaceuticals, Inc. from April 01, 2022. Mr. Savov graduated at the Dimitar A. Tsenov Academy of Economics as a magister of economics...